EA200000918A1 - Способ изготовления глазных препаратов местного применения без общих действий - Google Patents

Способ изготовления глазных препаратов местного применения без общих действий

Info

Publication number
EA200000918A1
EA200000918A1 EA200000918A EA200000918A EA200000918A1 EA 200000918 A1 EA200000918 A1 EA 200000918A1 EA 200000918 A EA200000918 A EA 200000918A EA 200000918 A EA200000918 A EA 200000918A EA 200000918 A1 EA200000918 A1 EA 200000918A1
Authority
EA
Eurasian Patent Office
Prior art keywords
drugs
timolol
clonidine
preparations
topically
Prior art date
Application number
EA200000918A
Other languages
English (en)
Russian (ru)
Inventor
Бакулиш Мафатлал Хамар
Original Assignee
Бакулиш Мафатлал Хамар
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Бакулиш Мафатлал Хамар filed Critical Бакулиш Мафатлал Хамар
Publication of EA200000918A1 publication Critical patent/EA200000918A1/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
EA200000918A 1999-02-03 2000-02-02 Способ изготовления глазных препаратов местного применения без общих действий EA200000918A1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN90BO1999 IN185228B (el) 1999-02-03 1999-02-03
PCT/IN2000/000008 WO2000049990A2 (en) 1999-02-03 2000-02-02 The process for manufacturing topical ophthalmic preparations without systemic effects

Publications (1)

Publication Number Publication Date
EA200000918A1 true EA200000918A1 (ru) 2001-10-22

Family

ID=11077485

Family Applications (1)

Application Number Title Priority Date Filing Date
EA200000918A EA200000918A1 (ru) 1999-02-03 2000-02-02 Способ изготовления глазных препаратов местного применения без общих действий

Country Status (11)

Country Link
EP (1) EP1139970A2 (el)
AP (1) AP2000001977A0 (el)
AU (1) AU4429100A (el)
BR (1) BR0004530A (el)
CA (1) CA2326690A1 (el)
EA (1) EA200000918A1 (el)
ID (1) ID28121A (el)
IL (1) IL138824A0 (el)
IN (1) IN185228B (el)
WO (1) WO2000049990A2 (el)
ZA (1) ZA200006252B (el)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2005220199B2 (en) * 2000-07-14 2007-03-08 Allergan, Inc. Compositions containing alpha-2-adrenergic agonist components
IL151530A0 (en) * 2000-07-14 2003-04-10 Allergan Sales Inc Compositions containing alpha-2-adrenergic agonist components
US8858961B2 (en) 2000-07-14 2014-10-14 Allergan, Inc. Compositions containing alpha-2-adrenergic agonist components
DE10132876A1 (de) * 2001-07-06 2003-01-30 Medproject Pharma Entwicklungs Zweiphasige, tropfbare Hydrogele zur Anwendung am Auge
US7439241B2 (en) 2003-05-27 2008-10-21 Galderma Laboratories, Inc. Compounds, formulations, and methods for treating or preventing rosacea
ES2424644T3 (es) 2004-05-25 2013-10-07 Galderma Pharma S.A. Compuestos, formulaciones y métodos para tratar o prevenir los trastornos inflamatorios de la piel
EP2329849B1 (en) 2009-11-18 2015-04-29 Galderma Research & Development Combination of alpha-2 adrenergic receptor agonist and non-steroidal anti-inflammatory agent for treating or preventing an inflammatory skin disorder
FR2977493B1 (fr) 2011-07-05 2014-02-14 Galderma Res & Dev Nouvelle composition anesthesique stable pour la reduction des reactions cutanees
RU2641021C2 (ru) * 2013-02-15 2018-01-17 Аллерган, Инк. Имплантат для пролонгированной доставки лекарственного средства
WO2014150899A1 (en) * 2013-03-15 2014-09-25 Chapin Matthew J Topical ophthalmic formulations for treating migraine
WO2016172712A2 (en) 2015-04-23 2016-10-27 Sydnexis, Inc. Ophthalmic composition
US9421199B2 (en) 2014-06-24 2016-08-23 Sydnexis, Inc. Ophthalmic composition
US11382909B2 (en) 2014-09-05 2022-07-12 Sydnexis, Inc. Ophthalmic composition
JP2018521000A (ja) 2015-05-29 2018-08-02 シドネキシス，インク． Ｄ２ｏで安定化された医薬製剤
GB202110420D0 (en) * 2021-07-20 2021-09-01 Rosemont Pharmaceuticals Ltd Liquid pharmaceutical composition of clonidine

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6056684B2 (ja) * 1977-11-07 1985-12-11 東興薬品工業株式会社 点眼剤
DD294174A5 (de) * 1990-05-04 1991-09-26 Sigrid Keipert Ophthalmika mit retardwirkung und ein neues verfahren zu ihrer herstellung
FR2678832B1 (fr) * 1991-07-10 1995-03-17 Europhta Sa Laboratoire Nouvelles compositions ophtalmiques a resorption amelioree et leurs procedes de preparation.
FR2679773A1 (fr) * 1991-07-30 1993-02-05 Merck Sharp & Dohme Preparation ophtalmique contenant un agent osmotique acceptable antimicrobien.
DE19614823A1 (de) * 1996-04-15 1997-10-16 Mann Gerhard Chem Pharm Fab Ophthalmische Zusammensetzung mit verlängerter Verweilzeit am Auge

Also Published As

Publication number Publication date
IL138824A0 (en) 2001-10-31
ZA200006252B (en) 2001-11-29
CA2326690A1 (en) 2000-08-31
AU4429100A (en) 2000-09-14
WO2000049990A2 (en) 2000-08-31
ID28121A (id) 2001-05-03
WO2000049990A3 (en) 2001-07-26
AP2000001977A0 (en) 2000-12-31
BR0004530A (pt) 2001-04-03
EP1139970A2 (en) 2001-10-10
IN185228B (el) 2000-12-09

Similar Documents

Publication Publication Date Title
EA200000918A1 (ru) Способ изготовления глазных препаратов местного применения без общих действий
HK1067984A1 (en) Compositions comprising ipatropium and xylometazoline for treatment of the common cold
ATE535257T1 (de) Ophthalmologische formulierung mit methylsulfonylmethan und ciprofloxacin
WO2004041153A3 (en) Pharmaceutical composition including low dosages of desmopressin
NO20024733D0 (no) Hydrofile molekyl¶rdisperse lösninger av karvedilol
WO2006093784A3 (en) Dosage forms of antibiotics and combinations of antibiotics ans symptomatic relief agents
MA27734A1 (fr) DERIVES HEXAHYDROPYRAZINO [1,2-a]PYRIMIDINE-4,7-DIONE SUBSTITUES SUR L'AZOTE, METHODE POUR LEUR PRODUCTION ET LEUR UTILISATION EN TANT QUE MEDICAMENTS
CA2585266C (en) Ophthalmic compositions and methods of using the same
BR0215238A (pt) Uso de nanopartìculas inor ânicas sintéticas como veìculos para drogas oftálmicas e óticas
WO2002096432A3 (en) Hypotensive lipid (prostaglandin derivatives) and timolol compositions and methods of using same
BR0305628A (pt) Composição farmacêutica para tratar disfunção sexual num mamìfero compreendendo peptìdeo e seu uso
ZA200201903B (en) Use of H1 antagonist and a safe steriod to treat eye conditions.
WO2003015703A3 (en) Compositions and methods relating to novel benzodiazepine compounds and targets thereof
WO2000037080A1 (en) Ophthalmic compositions comprising pheniramine and povidone
BR0114196A (pt) Formas polimórficas de maleato de 5-[4-[2-[n-metil-n-(2-piridil) amino]etóxi]benzil]tiazolidina-2,4-diona e processo para a preparação das mesmas.
BR0313207A (pt) Comprimidos de fosinopril de sódio estável ao armazenamento, processo para sua preparação e método para tratar a hipertensão
US20160310416A1 (en) Compositions containing alpha-2-adrenergic agonist components
EP0048023A2 (en) Composition for treating and preventing irritation of the eyes
JP5132015B2 (ja) 点眼剤組成物
EP0673250B1 (en) Ophthalmic compositions comprising emedastine and their use for treating allergic conjunctivitis
DE60320034D1 (de) Behandlung von mastitis mit einer kombination aus prednisolon und cephalosporin
JPH11189533A (ja) 点眼薬
DE69635806D1 (de) Diphosphonat derivate von therapeutisch wirksamen stoffen
KR20130092957A (ko) 안과용 처방용 보존제 조성물의 조합
Davey The Treatment of Leprosy with Sulphetrone.